Article COMPLAINING about Plandai's coming monopoly:
[The following is not coming from a pro-TXTM stock pumper, but to the contrary, comes from a hostile witness; thus adding major credibility in my eyes, fwiw.]
PART 1: THE SET-UP FOR WORLDWIDE MONOPOLY Plandai Biotechnology, Inc. Petitions South Africa Department of Health for License to Conduct Cannabis Research The current legal action in South Africa was initiated by Plandai Biotechnology, a privately owned company of U.S. investors based in Seattle, America, who own a farm called Senteeko in Mpumalanga, South Africa. They were granted loans from the Department of Trade and Industries and the SA Land Bank (R100 Million) in 2014, and propose to use their patented “delivery system” combined with “cannabinoids” in pharmaceutical preparations. This company negotiated with the Director General of the Dept. of Health, the Dept. of Trade and Industries and other government agencies and parties to amend certain laws in 2014 and since, to pave the way for the implementation of the Bill. Skip ahead... This company, and to a lesser extent its subsidiary licensees, will be the sole beneficiary of all proceeds of the Cannabis industry in South Africa.
Now pause to let that sink in . . . . . . .
The author's conclusion?
HOW TERRIBLE (that Plandai would be the sole beneficiary)!